IC,Ranking,Bonus,Contests, Bragging Rights= Bullshit

Most of us here realize the quagmire we are in and are trying to survive until our life raft comes along. Sometimes we can’t take the bullshit games anymore and jump ship without as much as a rubber raft to keep us afloat.
The Playing Field here is never equal for many reasons some being reimbursement,demographics,poor states vs prosporus states,weighted quotas with no explanation as to whether it’s punishment or trying to set you up for failure. How many times have you seen your trimester goals and know you are getting hosed? All the while others get a negative goal increase . They make the IC, award points, big pay raises etc.
to hear bragging about selling in this industry is a joke! We are not on a level playing field and many play with a handicap imposed by upper management just to screw with you..
An ape in a tie can do our jobs now. We are not allowed to think, talk or sell anything unless it’s scripted BS contrived by those in Marketing that are barely out of pampers and never sold in this industry.
Some will brag”I carried a bag for 2 years and I know what you go thru”, Not hardly!
Great Account Managers have great years, so so years, and bad years but they keep pushing on.
If you do well thank God and wait for the axe to fall next trimester, You control nothing in Pharma, draw your check, ask yourself if this is an industry you want to stay in thru it’s decline or perhaps measure your talents and go where you make a difference and can actually sleep at night because what you do really adds value to your life.
Signed,
I. Chong, Ancient Chinese Philosopher

 

IC quotas are designed to show favoritism. Why do some constantly get increases and some get 0 to a drop in quota?? Seems like the ass kissers get a break. One last thing, why doesn’t Lundbeck ever look at a problem ASM and get rid them? Talk about protecting your own!

 

This thread. Moronic

Do whatever you’d like to do with your life and fuck off.

Best philosophical advice

 

Your limited vocabulary and lack of attention to the detail of the thread tells me you probably drag your knuckles on the ground when you walk and can scratch your kneecaps with long hairy I clipped fingernails when you do stand upright. A typical response from a Pharma rep with a liberal arts degree and a tee time at 2:00 every afternoon. I’ll bet you have some odd looking clubs to accommodate those long hairy arms. Do they let people with your low intellectual prowess drive a golf cart or do you drag your golf bag with your long canine teeth?
Your response is so typical of what Pharma has become-knee jerk reactionaries with no concept of what this industry used to represent.

 

You might try sampling some Rex. as you appear to be quite unhinged.

 

Why? Because I didn’t use a pathetic loser FU remark like you? An aerodyte description of someone that can barely pen one sentence. You are the sad/mad one. Maybe Lundbeck is the place for you.

 

The sooner we start fresh with real quotas on neuro for an orphan drug the better off this company will be. With no teeth in the game here they should reset the bar since the company can't find a CEO. Back to days when xenazine had 1 start a trimester that was realistic.... seriously some territories have 50-100 trx goals a month.

Home office has to change and start recognizing the unbalanced compensation that has permeated in neuro. 75% of goal as a minimum is insulting. You wonder why we even try at this point. They give us a reimbursement book as another tool to comfort those who have heard from their patients about 2000+ dollar copays. Medicare D patients on an avg dose will pay 7000 a year. Seriously who has this kind of money to fork out as a "fair share". 5% of 13,000 is still a lot of money when you are catastrophic. When we have to sell managed care as much as we are, that tells you we are going over the cliff.

All those patient profiles (yes psych side, we used to have them too), it would be interesting to hear from them now. Probably all are without medication. Meanwhile the turnstile continues because you pay out poorly and do not recognize the unbalanced pay/compensation structure here.

 

They can't find a CEO because who wants to run a pharma company with 1 drug in the pipeline, and several long shot add on indications for a me-too drug. Add on the problem of not having a real marketing department, and is obsessed with stupid patient profiles and come out with nothing else, you can see why nobody wants to try and turn this thing around. Yes, the quotas are a real problem, but they won't do anything about it.

We need a complete change in upper management, and a real major one in lower management. We have, by far, the worst group of ASM's in the industry. The stupid surveys give a false impression of what the field thinks because the first damn question is so-and-so your manager! Who in the hell does that if they want genuine answers??? They need to give these guys 12 or so reps lie other companies do, and get rid of some of the ones that are "problems".

The timing of the meeting may be to introduce the new salesforce. Who knows, and at this point I doubt many of us will be here to even go to it!

 

Amen! Clean house from top to bottom- they all need to go- primary care wannabe managers at all levels- Alphas with 8 call a day goals- they force every single rep to lie- feed the bean counters.

 

Kids, it’s all about the pipeline. Rearranging the chairs on the titanic won’t suddenly invent you a drug. You guys aren’t going to cough up 5 billion plus for something promising in late development.

All you neuro reps are TOAST!

 

Or maybe he is one of the favored ones with a territory with no goal increases, always winning awards and making 25,000 in bonus every trimester. Must be nice

 

For the right opportunity I’m looking to leave but I’m oretty sure they’re going to need us through 2021 to sell Northera.

 

Will be interesting to see what happens with neuro sales force.

This company will be flat up broke without Onfi, so we shall see how many reps they can afford to carry. Last I heard, Valby was sick of throwing money at Northera trying to achieve peak sales “forecast” at acquisition.

 

The share we own in the psych drugs can easily be divested as well as Northera. Lundbeck is a hybrid contract company that can fold their tent and disappear. No one would remember the two floors we rent in Deerfield in less than 90 days. This is not a GSK or Lilly it Takeda for that matter with Campuses in RTP, Indianapolis, or in Deerfield like Takeda. We rent two floors because we are an experiment that did not work out quite the way it was planned. All the screw ups with the FDA on the new drugs has left This company a shell.

 

will be interesting to see what happens with the bloated psych sales force that has two sets of external partners selling their products, make you wonder what the purpose of a Lundbeck Psych sales force is? Maybe they will return to a lean rare disease orphan drug company and drop the excess baggage,

 

The purpose was a contract with Otsuka and Takeda based on Metrics and a percent of the sales. This company hedged their bets and had hoped to wean themselves away from their benefactors. Our drugs didn’t come thru the last five years so Lundbeck has no legs. Lundbeck has some money so why not move to the sidelines and start fresh with new drugs for CNS in a few years. Everyone who built Lundbeck US has left except Peter and John and their loyal minions.

 

Psych will be cut back but there will be no return to rare disease. The pedigree of the leadership is psych with some neuro and not rare disease. The future of the company is branded va branded dog fights with moderate differentiation.

 

When Steffan left, that was the alarm bell, not to mention the others. So many, many of the people I met at Lundbeck border on being delusional about the situation here. Some refuse to even look to see what's out there, which is plan stupidity. One person actually told me they were too lazy to even go to Indeed.com just to see what's there. If nothing else, Lundbeck needs to restructure it's sales team. How many times have people on Cafepharma complained about ASM's with way to few reps, and the micromanagement it creates, not to mention it's just bad business.

Now the rumors are flying about another Lundbeck M&A, IN the psych arena! Companies that have very early stage CNS products that all have high failure rates , not to mention a long time left in research to see if they even work. How many are "me-too" drugs? Something is going to change drastically over the next few months.

I got out, and so far, it's been a good move. How many of you still have your head in the sand for whatever reason? Better pull it out, and quick. Good luck to you all.

 

This.

Many of you guys only have the perspective of Ovation products. This is a one hundred year old psych R&D based regional company. Only neuro drugs it ever had were purchased from someone else and the only US presence it has is due to buying Ovation and partnerships.

Problem is it’s impossible to survive focusing on psych products and European market. All the steps they have taken over last 10 years have failed to alter this fact. Now they have a pipeline with 1 product that is years away and a few neuro moonshots that are 10 years away. Doubt they survive that long.